Article Versions Notes

Zhong R, Schimanski T, Zhang F, Lan H, Hohn A, Xu Q, Huang M, Liao Z, Qiao L, Yang Z, et al. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. International Journal of Molecular Sciences. 2022; 23(15):8313. https://doi.org/10.3390/ijms23158313

Zhong, Rujia, Theresa Schimanski, Feng Zhang, Huan Lan, Alyssa Hohn, Qiang Xu, Mengying Huang, Zhenxing Liao, Lin Qiao, Zhen Yang, and et al. 2022. "A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells" International Journal of Molecular Sciences 23, no. 15: 8313. https://doi.org/10.3390/ijms23158313

Zhong, R., Schimanski, T., Zhang, F., Lan, H., Hohn, A., Xu, Q., Huang, M., Liao, Z., Qiao, L., Yang, Z., Li, Y., Zhao, Z., Li, X., Rose, L., Albers, S., Maywald, L., Müller, J., Dinkel, H., Saguner, A., ... El-Battrawy, I. (2022). A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. International Journal of Molecular Sciences, 23(15), 8313. https://doi.org/10.3390/ijms23158313